ETF profile for Defiance Daily Target 2X Long Mrna ETF (MRNX) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
MRNX ETF Profile
| Family: |
Defiance ETFs |
| Name: |
Defiance Daily Target 2X Long MRNA ETF |
|
|
| Inception Date: |
3-Feb-2026 |
| Termination Date: |
|
| Investment Objective: |
The Defiance Daily Target 2X Long MRNA ETF (MRNX) provides investors with amplified long exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of messenger RNA (mRNA)-based medicines and vaccines. Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do not use leverage. The Fund seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Moderna, Inc. (NASDAQ: MRNA). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day. The Fund is an actively managed exchange traded fund ("ETF") that attempts to achieve two times (200%) the daily percentage change in the share price of the Underlying Security by employing derivatives, namely swap agreements and/or listed options contracts. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| MODERNA INC SWAP NOMURA-L |
|
129.1500% |
| Cash & Other |
|
-120.6900% |
| United States Treasury Bill 11/19/2026 |
B 0 11/19/26 |
20.7000% |
| MODERNA INC SWAP MAREX-L |
|
19.4100% |
| MODERNA INC SWAP CS-L |
|
16.1100% |
| MODERNA, INC.-SWAP-NBCB-L |
|
16.0700% |
| MODERNA INC SWAP CF-L |
|
8.7100% |
| MODERNA, INC.-SWAP-JNST-L |
|
7.2200% |
| MODERNA, INC.-SWAP-BMOB-L |
|
3.2500% |
|
Top 10 Holdings Weight: |
99.9% |
| Number of Holdings: |
9 |
| Shares Outstanding: |
220,000 |
| Total Net Assets: |
45,401,400 |
| NAV: |
207.03 |
| Net Expense Ratio: |
1.34% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Large Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
Leveraged (2x) |
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
